Here’s a rephrased version of the article:
LEXINGTON, Ky. (Sept. 25, 2024) — For nearly four decades, Robert J. Kuhn, Pharm.D., the Kentucky Hospital Association Endowed Professor, has been a cornerstone of the University of Kentucky College of Pharmacy. As World Pharmacist Day is celebrated, Kuhn’s remarkable career exemplifies the critical contributions pharmacists make, particularly in specialized areas such as pediatric pharmacotherapy and cystic fibrosis care. His work underscores the profound impact pharmacists have not only on patients’ lives but also on the future direction of the profession.
Kuhn’s path to pharmacy began humbly in a small-town drugstore, where a summer job ignited his passion for healthcare. From these early experiences, he ascended to become a leader in pediatric pharmacy, revolutionizing treatment protocols for children with cystic fibrosis. His groundbreaking innovations have extended patients’ lives and set new standards in clinical care.
A pivotal moment in Kuhn’s career occurred when he volunteered at a camp for children with cystic fibrosis, igniting a lifelong commitment to improving care for these patients.
“Bob’s contributions have advanced pediatric pharmacy practice, especially for children with cystic fibrosis,” said Milap Nahata, Pharm.D., a longtime colleague and mentor. Kuhn’s advocacy for pharmacists’ integration into multidisciplinary teams has reshaped cystic fibrosis care centers across the United States.
Kuhn’s work has earned him numerous prestigious awards, highlighting his national and international influence. Among them are the Richard Helms Award for Excellence in Pediatric Pharmacy Practice, the ACCP Pediatric PRN Outstanding Achievement Award, and the ASHP Outstanding Preceptor of the Year Award. On a local level, he has been honored as Pharmacist of the Year by the Kentucky Society of Health-System Pharmacists, received the Paul Parker Award, and been named an Honorary UK Pharmacy Resident. These accolades reflect the profound respect Kuhn commands within the pharmacy community.
Beyond his clinical achievements, Kuhn has made a lasting impact by mentoring future leaders in pediatric pharmacy, shaping the careers of over 40 pharmacy residents, many of whom now hold leadership positions in the field. One such former resident, Elizabeth Autry, Pharm.D., spoke to his lasting influence:
“Thanks to his vision, pediatric pharmacy services have expanded tremendously. His mentorship opened doors for me academically, clinically, and professionally. It’s an honor to be one of his graduates.”
Kuhn’s colleague, Jamshed Kanga, M.D., chief of pediatric pulmonology at Kentucky Children’s Hospital, also emphasized Kuhn’s significant contributions:
“His efforts led to the approval of ciprofloxacin for children with cystic fibrosis, a major milestone in treatment outcomes,” Kanga said. Kuhn’s push to integrate pharmacists into cystic fibrosis care teams set a new standard for collaborative healthcare.
Pharmacy Dean Kip Guy expressed his gratitude for Kuhn’s contributions:
“Dr. Robert Kuhn’s career exemplifies the highest standards of excellence in pharmacy. His work in pediatric pharmacotherapy, especially cystic fibrosis care, has transformed countless lives. He has not only reshaped clinical care but has also inspired a new generation of pharmacists through his mentorship, education, and leadership. We are incredibly fortunate to have had him as part of our faculty, and his legacy will endure at the University of Kentucky and beyond.”
Nahata echoed these sentiments, noting Kuhn’s lasting influence on pharmacy and beyond.
“I deeply admire Bob’s values and am proud of his many accomplishments and honors. His work with cystic fibrosis patients was instrumental in establishing the crucial role pharmacists play on cystic fibrosis care teams nationwide.”
As an educator and leader, Kuhn took pride in creating a program that not only produced skilled pharmacists but also compassionate caregivers. Former mentees often recall his unwavering commitment to patient care. Autry shared one of Kuhn’s guiding principles — that nothing is more important than the care of a sick child — a philosophy that became central to his teaching and clinical practice. This ethos is evident in the thriving network of pediatric pharmacists he has helped cultivate.
Though Kuhn is retiring, his commitment to advancing the field remains. As a founding and current board member of Mission Health Lexington, also known as Faith Pharmacy, he continues to contribute to the profession. In retirement, he plans to mentor the next generation of pediatric pharmacists while enjoying more time with his wife, Jan, and their four grandchildren.
Reflecting on his career, Kuhn hopes to be remembered for his dedication to patient care and expanding the role of pharmacists in healthcare:
“Just because pharmacists haven’t traditionally been involved in something doesn’t mean they can’t be.”
As Kentucky’s flagship, land-grant institution, the University of Kentucky is dedicated to advancing the Commonwealth. Through a commitment to education, research, service, and healthcare, UK prepares the next generation of leaders and transforms lives across the state. The university is proud to be a catalyst for breakthroughs and a force for healing, driven by its community of visionaries, pioneers, and innovators across 200 academic programs, a $476.5 million research and development enterprise, and a world-class medical center.
In 2022, UK was ranked by Forbes as one of the “Best Employers for New Grads” and recognized as a “Diversity Champion” by INSIGHT into Diversity, underscoring its commitment to advancing Kentucky and fostering a community of belonging for all. While the university’s mission has evolved since its founding in 1865, its vision of service to the Commonwealth and the world remains steadfast. UK continues to be the University for Kentucky.
